Mustang Bio, Inc. SEC filings MBIO
Mustang Bio, Inc. has 405 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 17, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 23, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Other events
|
Jul 9, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Feb 27, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Feb 21, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Feb 13, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 11, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jan 17, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jan 2, 2025 | Dec 26, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Nov 15, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Oct 25, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 13, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Shareholder vote results
|
Jul 3, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 24, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 6, 2024 | May 31, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
May 21, 2024 | May 16, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 2, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Apr 12, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 15, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Dec 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 30, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Other events
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Other events
|
Oct 4, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Other events
|
Aug 16, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jul 31, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 20, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Agreement ended
|
Jul 11, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Exit or restructuring costs, Other events
|
May 22, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 8-K |
Current report
Other events
|
Apr 20, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Agreement ended
|
Apr 13, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Apr 3, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Mar 3, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 13, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Other events
|
Nov 25, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 7, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Listing notice
|
May 31, 2022 | May 24, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2022 | Apr 18, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2022 | Mar 11, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 8, 2022 | Mar 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Auditor change
|
Sep 28, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Auditor change
|
Sep 24, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 22, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 14, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Other events
|
Dec 31, 2020 | Dec 31, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 4, 2020 | Dec 4, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2020 | Nov 6, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Other events
|
Jul 24, 2020 | Jul 20, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 19, 2020 | Jun 17, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 15, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 30, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2019 | Aug 9, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 19, 2019 | Jun 18, 2019 |
| 8-K |
Current report
Results of operations
|
May 10, 2019 | May 10, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 30, 2019 | Apr 30, 2019 |
| 8-K |
Current report
Material agreement
|
Apr 4, 2019 | Mar 29, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2019 | Mar 18, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2018 | Nov 13, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2018 | Aug 13, 2018 |
| 8-K |
Current report
Other events
|
Jul 27, 2018 | Jul 27, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2018 | Jun 14, 2018 |
| 8-K |
Current report
Results of operations
|
May 15, 2018 | May 14, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2018 | Mar 29, 2018 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 14, 2017 | Nov 14, 2017 |
| 8-K |
Current report
Material agreement
|
Oct 30, 2017 | Oct 27, 2017 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2017 | Aug 14, 2017 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2017 | Jun 7, 2017 |
| 8-K |
Current report
Other events
|
Jun 9, 2017 | Jun 9, 2017 |
| 8-K |
Current report
Material agreement
|
Jun 6, 2017 | May 31, 2017 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2017 | Apr 24, 2017 |
| 8-K |
Current report
Material agreement
|
Mar 23, 2017 | Mar 17, 2017 |
| 8-K |
Current report
Material agreement
|
Feb 24, 2017 | Feb 17, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 6, 2017 | Jan 31, 2017 |
| 8-K |
Current report
Material agreement
|
Jan 6, 2017 | Dec 30, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 3, 2017 | Dec 28, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 16, 2016 | Dec 12, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 6, 2016 | Nov 30, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 31, 2016 | Oct 25, 2016 |
| 8-K |
Current report
Auditor change
|
Oct 25, 2016 | Oct 20, 2016 |
| 8-K |
Current report
Other events
|
Oct 20, 2016 | Oct 20, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 6, 2016 | Sep 30, 2016 |
| 8-K |
Current report
Auditor change
|
Oct 5, 2016 | Sep 29, 2016 |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1680048
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.